Free Trial
NYSE:CNC

Centene (CNC) Stock Price, News & Analysis

Centene logo
$56.55 +0.19 (+0.33%)
As of 10:17 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Centene Stock (NYSE:CNC)

Advanced

Key Stats

Today's Range
$55.78
$56.65
50-Day Range
$31.72
$56.35
52-Week Range
$25.08
$62.21
Volume
270,529 shs
Average Volume
6.61 million shs
Market Capitalization
$27.92 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$53.82
Consensus Rating
Hold

Company Overview

Centene Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
51st Percentile Overall Score

CNC MarketRank™: 

Centene scored higher than 51% of companies evaluated by MarketBeat, and ranked 452nd out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Centene has received a consensus rating of Hold. The company's average rating score is 2.32, and is based on 1 strong buy rating, 6 buy ratings, 10 hold ratings, and 2 sell ratings.

  • Upside/Downside

    The consensus price target for Centene is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Centene has been the subject of 18 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Centene's stock forecast and price target.
  • Earnings Growth

    Earnings for Centene are expected to grow by 26.96% in the coming year, from $3.45 to $4.38 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Centene is -4.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Centene is -4.29, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Centene has a PEG Ratio of 1.08. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Centene has a P/B Ratio of 1.38. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Centene's valuation and earnings.
  • Percentage of Shares Shorted

    3.10% of the float of Centene has been sold short.
  • Short Interest Ratio / Days to Cover

    Centene has a short interest ratio ("days to cover") of 1.85, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Centene has recently increased by 10.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Centene does not currently pay a dividend.

  • Dividend Growth

    Centene does not have a long track record of dividend growth.

  • News Sentiment

    Centene has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 11 news articles for Centene this week, compared to 11 articles on an average week.
  • Search Interest

    38 people have searched for CNC on MarketBeat in the last 30 days. This is an increase of 280% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Centene to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Centene insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.37% of the stock of Centene is held by insiders.

  • Percentage Held by Institutions

    93.63% of the stock of Centene is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Centene's insider trading history.
Receive CNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Stock News Headlines

CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel
See More Headlines

CNC Stock Analysis - Frequently Asked Questions

Centene's stock was trading at $41.18 on January 1st, 2026. Since then, CNC stock has increased by 36.8% and is now trading at $56.3480.

Centene Corporation (NYSE:CNC) posted its earnings results on Tuesday, April, 28th. The company reported $3.37 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.23 by $1.14. The business's quarterly revenue was up 7.1% on a year-over-year basis.
Read the conference call transcript
.

Centene's stock split on the morning of Wednesday, February 6th 2019.The 2-1 split was announced on Tuesday, February 5th 2019. The newly minted shares were payable to shareholders after the closing bell on Tuesday, February 5th 2019. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Centene subsidiaries include Magellan Health Inc, PANTHERx Rare Pharmacy, Apixio, WellCare Health Plans, Community Medical Group, MHM, Fidelis Care, and more.

Centene's top institutional shareholders include Assenagon Asset Management S.A. (0.78%), Dimensional Fund Advisors LP (0.57%), Bank of New York Mellon Corp (0.51%) and Swiss National Bank (0.29%). Insiders that own company stock include Sarah London, Andrew Lynn Asher, Kenneth J Fasola, Theodore R Samuels II, Christopher J Coughlin, Lori Jean Robinson and H James Dallas.
View institutional ownership trends
.

Shares of CNC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centene investors own include Humana (HUM), NVIDIA (NVDA), Meta Platforms (META), American Water Works (AWK), Salesforce (CRM), Advanced Micro Devices (AMD) and Verizon Communications (VZ).

Company Calendar

Last Earnings
4/28/2026
Today
5/12/2026
Next Earnings (Estimated)
7/28/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED - HMO
Sub-Industry
Managed Health Care
Current Symbol
NYSE:CNC
CIK
1071739
Employees
61,100
Year Founded
1984

Price Target and Rating

High Price Target
$68.00
Low Price Target
$37.00
Potential Upside/Downside
-4.8%
Consensus Rating
Hold
Rating Score (0-4)
2.32
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
($13.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
16.39
P/E Growth
1.08
Net Income
-$6.67 billion
Net Margins
-3.25%
Pretax Margin
-3.22%
Return on Equity
5.57%
Return on Assets
1.54%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
1.12
Quick Ratio
1.12

Sales & Book Value

Annual Sales
$194.78 billion
Price / Sales
0.14
Cash Flow
$4.74 per share
Price / Cash Flow
11.94
Book Value
$40.76 per share
Price / Book
1.39

Miscellaneous

Outstanding Shares
493,800,000
Free Float
491,970,000
Market Cap
$27.92 billion
Optionable
Optionable
Beta
1.06

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:CNC) was last updated on 5/12/2026 by MarketBeat.com Staff.
From Our Partners